{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T21:27:10Z","timestamp":1764970030657,"version":"3.46.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"DOI":"10.7759\/cureus.98539","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T21:24:17Z","timestamp":1764969857000},"source":"Crossref","is-referenced-by-count":0,"title":["SMARCB1-Deficient Renal Medullary Carcinoma: A Case Report Highlighting the Value of History and Race Information"],"prefix":"10.7759","author":[{"given":"Habibat F","family":"Kolawole","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Cardenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aly-Khan A","family":"Lalani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bonert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2017.020909","article-title":"Renal medullary carcinoma: establishing standards in practice","volume":"13","author":"Beckermann KE","year":"2017","unstructured":"Beckermann KE, Sharma D, Chaturvedi S, et al.. Renal medullary carcinoma: establishing standards in practice. J Oncol Pract. 2017, 13:414-21. 10.1200\/JOP.2017.020909","journal-title":"J Oncol Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199501000-00001","article-title":"Renal medullary carcinoma. The seventh sickle cell nephropathy","volume":"19","author":"Davis CJ Jr","year":"1995","unstructured":"Davis CJ Jr, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol. 1995, 19:1-11. 10.1097\/00000478-199501000-00001","journal-title":"Am J Surg Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 World Health Organization classification of tumours of the urinary system and male genital organs\u2014part A: renal, penile, and testicular tumours","volume":"82","author":"Moch H","year":"2022","unstructured":"Moch H, Amin MB, Berney DM, et al.. The 2022 World Health Organization classification of tumours of the urinary system and male genital organs\u2014part A: renal, penile, and testicular tumours. Eur Urol. 2022, 82:458-68. 10.1016\/j.eururo.2022.06.016","journal-title":"Eur Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0206-1","article-title":"Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma","volume":"5","author":"Beckermann KE","year":"2017","unstructured":"Beckermann KE, Jolly PC, Kim JY, Bordeaux J, Puzanov I, Rathmell WK, Johnson DB. Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma. J Immunother Cancer. 2017, 5:1. 10.1186\/s40425-016-0206-1","journal-title":"J Immunother Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1073728","article-title":"Surgical and oncological management of renal medullary carcinoma in a young patient: a case report","volume":"13","author":"Courcier J","year":"2023","unstructured":"Courcier J, De La Taille A, Bertolo R, et al.. Surgical and oncological management of renal medullary carcinoma in a young patient: a case report. Front Oncol. 2023, 13:1073728. 10.3389\/fonc.2023.1073728","journal-title":"Front Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13236022","article-title":"Association of high-intensity exercise with renal medullary carcinoma in individuals with sickle cell trait: clinical observations and experimental animal studies","volume":"13","author":"Shapiro DD","year":"2021","unstructured":"Shapiro DD, Soeung M, Perelli L, et al.. Association of high-intensity exercise with renal medullary carcinoma in individuals with sickle cell trait: clinical observations and experimental animal studies. Cancers (Basel). 2021, 13:10.3390\/cancers13236022","journal-title":"Cancers (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13705","article-title":"Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study","volume":"120","author":"Shah AY","year":"2017","unstructured":"Shah AY, Karam JA, Malouf GG, et al.. Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study. BJU Int. 2017, 120:782-92. 10.1111\/bju.13705","journal-title":"BJU Int"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.2373","article-title":"Clinical outcome and prognostic factors in renal medullary carcinoma: a pooled analysis from 18 years of medical literature","volume":"9","author":"Iacovelli R","year":"2015","unstructured":"Iacovelli R, Modica D, Palazzo A, Trenta P, Piesco G, Cortesi E. Clinical outcome and prognostic factors in renal medullary carcinoma: a pooled analysis from 18 years of medical literature. Can Urol Assoc J. 2015, 9:E172-7. 10.5489\/cuaj.2373","journal-title":"Can Urol Assoc J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.185.1.01850268","article-title":"Renal medullary carcinoma: CT and MRI features","volume":"185","author":"Blitman NM","year":"2005","unstructured":"Blitman NM, Berkenblit RG, Rozenblit AM, Levin TL. Renal medullary carcinoma: CT and MRI features. AJR Am J Roentgenol. 2005, 185:268-72. 10.2214\/ajr.185.1.01850268","journal-title":"AJR Am J Roentgenol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000222","article-title":"Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity","volume":"38","author":"Amin MB","year":"2014","unstructured":"Amin MB, Smith SC, Agaimy A, et al.. Collecting duct carcinoma versus renal medullary carcinoma: an appeal for nosologic and biological clarity. Am J Surg Pathol. 2014, 38:871-4. 10.1097\/PAS.0000000000000222","journal-title":"Am J Surg Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.06.1124","article-title":"Renal medullary carcinoma: the Bronx experience","volume":"70","author":"Hakimi AA","year":"2007","unstructured":"Hakimi AA, Koi PT, Milhoua PM, et al.. Renal medullary carcinoma: the Bronx experience. Urology. 2007, 70:878-82. 10.1016\/j.urology.2007.06.1124","journal-title":"Urology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-4295(02)02154-4","article-title":"Renal medullary carcinoma: clinical, pathologic, immunohistochemical and genetic analysis with pathogenetic implications","volume":"60","author":"Swartz MA","year":"2002","unstructured":"Swartz MA, Karth J, Schneider DT, Rodriguez R, Beckwith JB, Perlman EJ. Renal medullary carcinoma: clinical, pathologic, immunohistochemical and genetic analysis with pathogenetic implications. Urology. 2002, 60:1083-9. 10.1016\/s0090-4295(02)02154-4","journal-title":"Urology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0273-1","article-title":"Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases","volume":"32","author":"Jia L","year":"2019","unstructured":"Jia L, Carlo MI, Khan H, et al.. Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases. Mod Pathol. 2019, 32:1329-43. 10.1038\/s41379-019-0273-1","journal-title":"Mod Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24795","article-title":"Renal medullary carcinoma in an adolescent with sickle cell anemia","volume":"61","author":"Marsh A","year":"2014","unstructured":"Marsh A, Golden C, Hoppe C, Quirolo K, Vichinsky E. Renal medullary carcinoma in an adolescent with sickle cell anemia. Pediatr Blood Cancer. 2014, 61:567. 10.1002\/pbc.24795","journal-title":"Pediatr Blood Cancer"},{"key":"ref15","article-title":"Renal medullary carcinoma: a case report and brief review of the literature","volume":"14","author":"Shetty A","year":"2014","unstructured":"Shetty A, Matrana MR. Renal medullary carcinoma: a case report and brief review of the literature. Ochsner J. 2014, 14:270-5.","journal-title":"Ochsner J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.70","article-title":"Uncommon and recently described renal carcinomas","volume":"22 Suppl 2","author":"Srigley JR","year":"2009","unstructured":"Srigley JR, Delahunt B. Uncommon and recently described renal carcinomas. Mod Pathol. 2009, 22 Suppl 2:S2-23. 10.1038\/modpathol.2009.70","journal-title":"Mod Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27714","article-title":"Physician and surgeon communication assessed via the pathology requisition in a regional laboratory over ten years","volume":"14","author":"Bonert M","year":"2022","unstructured":"Bonert M, Zafar U, Williams P, et al.. Physician and surgeon communication assessed via the pathology requisition in a regional laboratory over ten years. Cureus. 2022, 14:e27714. 10.7759\/cureus.27714","journal-title":"Cureus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2018.09.005","article-title":"Updated recommendations on the diagnosis, management, and clinical trial eligibility criteria for patients with renal medullary carcinoma","volume":"17","author":"Msaouel P","year":"2019","unstructured":"Msaouel P, Hong AL, Mullen EA, et al.. Updated recommendations on the diagnosis, management, and clinical trial eligibility criteria for patients with renal medullary carcinoma. Clin Genitourin Cancer. 2019, 17:1-6. 10.1016\/j.clgc.2018.09.005","journal-title":"Clin Genitourin Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/429343-smarcb1-deficient-renal-medullary-carcinoma-a-case-report-highlighting-the-value-of-history-and-race-information","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T21:24:18Z","timestamp":1764969858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/429343-smarcb1-deficient-renal-medullary-carcinoma-a-case-report-highlighting-the-value-of-history-and-race-information"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.98539","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,5]]}}}